source
- US Treasury proposes rule that could bar biotech investments in ChinaThe Treasury Department issued a proposed rule to implement the 2025 COINS Act, which governs U.S. investment in sensitive technologies in China and other countries. The proposal places a broad ra…
- Alnylam to launch pivotal Huntington’s trial after early study shows strong huntingtin knockdownAlnylam Pharmaceuticals announced plans to move its Huntington’s disease RNAi therapy brezosiran into a pivotal, placebo‑controlled trial slated for 2027, pending regulatory alignment. The decisio…